Treatment outcomes of tuberculosis patients under directly observed treatment short-course at Debre Tabor General Hospital, northwest Ethiopia: nine-years retrospective study

Infectious Diseases of Poverty
Seble WorkuFantahun Biadglegne

Abstract

Data regarding tuberculosis (TB) treatment outcomes, proportion of TB/HIV co-infection and associated factors have been released at different TB treatment facilities in Ethiopia and elsewhere in the world as part of the auditing and surveillance service. However, these data are missing for the TB clinic offering directly observed treatment short-course (DOTs) at Debre Tabor General Hospital (DTGH). The authors analysed the records of 985 TB patients registered at the DTGH from September 2008 to December 2016. Data on patients' sex, age, type of TB, and treatment outcomes were extracted from the TB treatment registration logbook. The treatment outcome of patients was categorized according to the National TB and Leprosy Control Program guidelines: cured, treatment completed, treatment failed, died, and not evaluated (transferred out and unknown cases). Around half of the registered patients were males (516, 52.4%). In terms of TB types, 381 (38.7%), 241 (24.5%), and 363 (36.9%) patients had smear-negative pulmonary TB, smear-positive pulmonary TB, and extra pulmonary TB, respectively. Six hundred and seventy-two patients (90.1%) had successful treatment outcomes (cured and treatment completed), while 74 patients (9.9%) had unsucc...Continue Reading

References

Mar 24, 1988·The New England Journal of Medicine·T I SørensenT W Teasdale
Aug 15, 2000·Neuroscience and Biobehavioral Reviews·S L Klein
Mar 21, 2006·Lancet·Mario C Raviglione, Mukund W Uplekar
Dec 23, 2009·PLoS Medicine·Olivier Neyrolles, Lluis Quintana-Murci
May 23, 2012·International Journal of Health Services : Planning, Administration, Evaluation·Debabar Banerji
Jul 9, 2013·The Brazilian Journal of Infectious Diseases : an Official Publication of the Brazilian Society of Infectious Diseases·Belete GetahunSibhatu Biadgilign
Jun 4, 2014·Tuberculosis Research and Treatment·Mengistu EndrisChandrashekhar Unakal
Dec 4, 2014·The Brazilian Journal of Infectious Diseases : an Official Publication of the Brazilian Society of Infectious Diseases·Mehretu BelaynehHailemariam Lemma
Mar 31, 2015·Lancet·Mukund UplekarUNKNOWN WHO's Global TB Programme
Aug 1, 2015·Journal of Infection in Developing Countries·Eyasu EjetaHaimanot Disassa
Oct 22, 2016·The Lancet Global Health· The Lancet Global Health
Nov 7, 2016·BMC Infectious Diseases·Solomon Ahmed AliTadesse Awoke

❮ Previous
Next ❯

Citations

Dec 28, 2019·PloS One·Ninfa Marlen Chaves TorresEduardo Martins Netto
Sep 3, 2020·Tropical Diseases, Travel Medicine and Vaccines·Getachew Kahsu Abay, Bahlbi Hailay Abraha
Mar 17, 2020·Archives of public health = Archives belges de santé publique·Atalay Mulu FentieTamrat Assefa
May 11, 2021·Frontiers in Public Health·Richard KiplimoJoseph Koske
Jul 1, 2021·Journal of Clinical Tuberculosis and Other Mycobacterial Diseases·Alexandra J ZimmerRobyn C Waite
Jul 31, 2021·Journal of Global Health·Rajaram Subramanian PottyReynold Washington

❮ Previous
Next ❯

Methods Mentioned

BETA
X-ray

Software Mentioned

SPSS
GeneXpert

Related Concepts

Related Feeds

Antitubercular Agents (ASM)

Antitubercular agents are pharmacologic agents for treatment of tuberculosis. Discover the latest research on antitubercular agents here.

Antitubercular Agents

Antitubercular agents are pharmacologic agents for treatment of tuberculosis. Discover the latest research on antitubercular agents here.